Finance ❯ Corporate Finance ❯ Revenue Growth
Market Forecasts Market Competition Annual Sales Market Trends Fiscal Year 2024
The move refocuses J&J on higher‑growth pharmaceuticals plus advanced medical technology, with a tax‑free split the preferred path.